Phase I study of the PARP inhibitor talazoparib with radiation therapy for locally recurrent gynecologic cancers

by David S. Lakomy, Diana L. Urbauer, Shannon N. Westin, Lilie L. Lin
Published 2020-03-01

Predicting treatment Response based on Dual assessment of magnetic resonance Imaging kinetics and Circulating Tumor cells in patients with Head and Neck cancer (PREDICT-HN): matchi...

by Sweet Ping Ng, Houda Bahig, Jihong Wang, Carlos E. Cardenas, Anthony Lucci, Carolyn S. Hall, Salyna Meas, Vanessa N. Sarli, Ying Yuan, Diana L. Urbauer, Yao Ding, Shane Ikner, Vi Dinh, Baher A. Elgohari, Jason M. Johnson, Heath D. Skinner, G. Brandon Gunn, Adam S. Garden, Jack Phan, David I. Rosenthal, William H. Morrison, Steven J. Frank, Katherine A. Hutcheson, Abdallah S. R. Mohamed, Stephen Y. Lai, Renata Ferrarotto, Michael P. MacManus, Clifton D. Fuller
Published 2018-09-01